Mission Bio Company
Leading precision medicine with the only single-cell multi-omics platform integrating genotype and phenotype
Investors
Connections from
Total Funding:
$110.1M
Headquarters:
Others
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Technology:
Non-clinical Applications
Investor Type:
For Profit
Investors Number:
12
Founded Date:
2012-01-01
Industry:
AI for Longevity